Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{170951,
        author = {Chinnam Sushma and Choda Prasanth Kumar},
        title = {INSULIN THERAPY FOR TYPE -1 DIABETIC PATIENTS},
        journal = {International Journal of Innovative Research in Technology},
        year = {2024},
        volume = {11},
        number = {7},
        pages = {2483-2484},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=170951},
        abstract = {Insulin is a peptide hormone produced by cells of the pancreatic islets encoded by the insulin gene. It regulates the metabolism of carbohydrates, fats, and protein by promoting the absorption of glucose from the blood into the cells of the liver, fat, and skeletal muscles. Insulin is used in the treatment of type-1 diabetes (insulin dependent diabetes). Recent advances in insulin therapy include ultra-rapid-acting insulin and ultra-long-acting basal insulin therapies. LEVEMIR is the most common insulin used in the treatment of diabetes.},
        keywords = {},
        month = {December},
        }